| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |